METADOL Strength
Active ingredient(s) See footnote 8 : Strength METHADONE HYDROCHLORIDE : 5 MG · DIN 02247699 · KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2
Health Canada status: MARKETED
What is METADOL?
METADOL Strength contains Active ingredient(s) See footnote 8 : Strength METHADONE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02247699, held by KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2, supplied as Tablet for Oral administration. Health Canada currently lists it as marketed, status dated 20-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is METADOL used for?
METADOL (methadone hydrochloride tablets, oral solution and concentrate) is indicated in adult patients for: the relief of severe pain. In general, METADOL, as an analgesic, should not be used in opioid naïve patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02247699 |
|---|---|
| Brand name | METADOL |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength METHADONE HYDROCHLORIDE : 5 MG |
| Manufacturer | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 |
| Strength | Strength |
| Dosage form | Tablet |
| Route of administration | Oral |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N07BC02 METHADONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Mar-2026 |
| Original market date | 2003-07-29 |
How is it stored and handled?
Diluted solutions should be refrigerated (2°C to 8°C) and stored for a period not exceeding 7 days in Allen’s® Apple Juice, and 14 days in all other diluents mentioned above.
How is it supplied?
Oral Tablets: 1, 5, 10 and 25 mg. Oral Solution: 1 mg/mL. Oral Concentrate: 10 mg/mL.
What can be used instead?
Other Canadian products sharing ATC code N07BC02 METHADONE. 19 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-METHADONE | 1 MG | TABLET | APOTEX INC | MARKETED | DIN 02533642 |
| APO-METHADONE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02533669 |
| APO-METHADONE | 25 MG | TABLET | APOTEX INC | MARKETED | DIN 02533677 |
| APO-METHADONE | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 02533650 |
| JAMP METHADONE ORAL CONCENTRATE | 10 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02495783 |
| METADOL | Strength | Solution | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 | MARKETED | DIN 02247694 |
| METADOL | Strength | Tablet | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 | MARKETED | DIN 02247698 |
| METADOL | Strength | Solution | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 | MARKETED | DIN 02241377 |
| METADOL | Strength | Tablet | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 | MARKETED | DIN 02247700 |
| METADOL | Strength | Tablet | KNIGHT THERAPEUTICS INC. 100 Alexis-Nihon Blvd., Suite 600 Montreal Quebec Canada H4M 2P2 | MARKETED | DIN 02247701 |
Who else supplies METHADONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHADONE appears in 54 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.